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A B S T R A C T
Psoriasis is a human chronic, immune disease with severe cutaneous and systemic manifestations. Its prevalence,
among the world population, highly varies with ethnicity and geography, but not sex from remarkable low levels
in Asia to 2.3% in Spain, or an impressive 11.5% in Norway. The pathogenesis of psoriasis derives from complex
genetic and environmental interactions, which creates aberrant crosstalk between keratinocytes and variated
immune cell, resulting in open amplified inflammatory and pro-proliferative circuits. Both, innate and adaptive
immune systems are known to be involved in the response at the cellular and humoral levels. Nevertheless, the
exact molecular mechanisms are still under debate. Therefore, discovering useful therapeutic targets to stretch
the molecular gaps in psoriasis pathogenesis and its associated comorbidities is still mandatory. So far, some
mutagenic or pharmacological studies in vitro or using comparative vertebrate models have provided critical
molecular insights and directed the human research. Although highly feasible in rodents, the versatile phy-
siology, genetic similarity to humans and outstanding molecular toolbox available, suggest that elaborate for-
ward genetic screenings are far easier to be conducted using the zebrafish model. Thus, in this review, we intend
to briefly overview psoriasis and revise in a digested fashion the preclinical research models available, em-
phasizing the zebrafish as a powerful tool in the study of immune effectors on the same, and how it supports the
discovering of new therapies that may help in controlling this widespread disease around the globe.
1. Introduction
Autoimmune and autoinflammatory disorders are a newly ex-
panding concept in most medical areas, but with substantial relevance
in the field of human dermatology (Murthy and Leslie, 2016). Among
the several non-pathogenic skin disorders reported so far, one of the
most recurrent is psoriasis. Psoriasis is a chronic, immune-mediated
skin-disease with strong inflammatory and systemic manifestations
which possess a complex genetic architectural background (Greb et al.,
2016a; Woo et al., 2017). The increasing public concern about psoriatic
elements is recurrently observed in the several research papers pub-
lished yearly on this topic, and hence the urgent necessity to increase
our knowledge of the mechanisms governing this widespread disease.
So far, the pathogenesis of psoriasis is inferred to be triggered by
traumatic, environmental or pharmacological mediators which induce
susceptible individuals to aberrant crosstalk between keratinocytes and
diverse immune cell types resulting in open amplified inflammatory
and pro-proliferative circuits. Such elaborated characteristics provide
the disease with extensive plasticity that allows it to manifest diverse
phenotypes. Clinical manifestations include psoriasis vulgaris, plaque
psoriasis, scalp psoriasis, guttate psoriasis, inverse psoriasis, ery-
throdermic psoriasis, palmoplantar psoriasis, and pustular psoriasis
(Lebwohl, 2018; Raposo and Torres, 2016; Renton, 2014; Syed and
Khachemoune, 2011). However, despite the particular phenotype ex-
pressed at a time, the pathophysiology in all psoriasis variants is
characterized by an abnormal keratinocyte proliferation and strong
immune cell infiltration among the different layers of the skin causing
shared symptoms that include: intense itching, burning, and soreness
(Ippagunta et al., 2016) (Fig. 1A). These symptoms mostly result from
the open recruitment of immune cells to specific skin sections, which
together with keratinocytes release potent inflammatory mediators, like
interleukins (Fig. 1B and C). All psoriatic phenotypes have been re-
ported worldwide with a global prevalence within adult populations,
regardless of sex, estimated at 3% of the total world population
(Lebwohl, 2003). However, prevalence estimates are strongly affected
by marked variations observed among ethnic groups and geographical
locations. In fact, reported incidence of psoriasis in Taiwan (0.19%)
(Chang et al., 2009) and Japan is low (0.30%) (Kubota et al., 2015),
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moderate in Spain (2.31%) (Ferrándiz et al., 2014) or USA (2.50%)
(Gelfand et al., 2005), and impressively high in Norway (11.43%), in-
dicating that different races had diverse genetic backgrounds that
profoundly affect the disease output (Danielsen et al., 2013). Patients
affected with psoriasis suffer not only the externally exposed physical
condition but, given its systemic characteristic, additional severe
pathologies expressed as comorbidities use to be present as well (Parisi
et al., 2013). Arthritis, autoimmune disease, cardiovascular disease,
chronic obstructive pulmonary disease, inflammatory bowel disease,
liver disease, metabolic syndrome, migraine, obesity, sleep apnea,
psychiatric illness, sexual dysfunction, and addictive behavior have
been repeatedly reported to promote a remarkably complicated disease
loop in psoriatic patients (Capo et al., 2018; Greb et al., 2016b; Molina-
Leyva et al., 2018). Moreover, patients suffering the combination of
extreme visually exposed psoriatic lesions, linked to a complex co-
morbidity ultimately can trigger an uncontrolled, strong emotional
stress burden, that in the worst scenario shall lead to suicidal behaviors
(Wu et al., 2017; Wu and Armstrong, 2018).
To understand the mechanisms associated with psoriasis, in vitro, ex-
vivo, and in vivo preclinical models of the human disease have been
described (Bocheńska et al., 2017; Danilenko, 2008; Hawkes et al.,
2018; Wcisło-Dziadecka et al., 2018). Notably, the murine models have
proven to be extremely valuable in investigating critical molecular
mechanisms that underlie the complex interplay between epidermal
keratinocytes, and the innate and adaptive immune system in human
psoriasis (Bezdek et al., 2018; Chuang et al., 2018; Nakajima and Sano,
2018). Nevertheless, this far, not any one of the systems mentioned
above are neither homologous nor isomorphic and do not entirely
phenocopy the human disease, suggesting the urgent necessity of
searching for alternative relevant matching models. In this regard, a
new player with particular characteristics has emerged in the last
decade to complement the research efforts achieved so far in under-
standing intimate mechanisms of inflammatory skin diseases, such as,
psoriasis. The zebrafish (Danio rerio) has striking similarities between
cells, tissues, and physiological functions to those of humans (Galindo-
Villegas, 2016). After its complete genome assembly, it was recognized
that more than 70% of all human genes have at least one ortholog in
zebrafish (Howe et al., 2013). Thus, by using the latest mutagenesis
resources diverse human disease models have been produced in this
model animal (Santoriello and Zon, 2012). Here, we briefly overview
psoriasis and review in a digested fashion relevant research models,
emphasizing on those using zebrafish that have been developed for the
study of immune effectors on the same, and thus to provide support on
discovering new therapies that may help on controlling this widespread
disease around the globe.
2. Pathogenesis of psoriasis
In all vertebrates, the skin consists of two multilayered regions, the
dermis, and the epidermis that is in contact with the environmental
factors. Keratinocytes constitute both layers, differentially represented
and stratified according to the taxonomic level of the host (Fig. 2A and
B) human and zebrafish, respectively. However, despite the species
represented, the basic morphology is always present and continuously
Fig. 1. General characteristics of psoriasis in humans. A) The abnormal keratinocyte proliferation produces characteristic sterile pustules overlying erythematous
skin in the extremities of an adult patient. Redness areas denote inflammation signs. B) Classical histologic biopsy of lesional pustular psoriasis. The black arrowhead
is pointing to an intense infiltration of immune cells affecting the different skin layers. (H&E, 30×). Scale bar 80 μm. C) RNA-seq data fold change showing
differential regulation of interleukins 1 to 36 in psoriatic lesions compared with healthy skin (Baliwag et al., 2015).
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renewing (Chermnykh et al., 2018). Keratinocytes are versatile cells
which perform diverse essential mechanical protective functions while
providing an immunological defense to the host (Johansen, 2017).
Thus, understanding the regulation of keratinocyte proliferation, their
complex functions, and the multiple interactions with immune cells is
fundamental to get track of the pathogenesis of psoriasis.
Despite psoriasis disease results from an immune disorder, at the
very early stage, a puzzling issue is that neither innate nor adaptive
cells are present in high numbers to produce the cytokines and related
chemokines required on site to activate an exacerbate the immune re-
sponse. Therefore, it has been proposed that environmental factors via
innate immune effectors, like the Toll-like receptors (TLRs), activate
keratinocytes to release potent inflammatory mediators and active
signaling molecules to recruit further macrophages, neutrophils, and
mast cells that will amplify the inflammatory network and trigger the
disease (Albanesi et al., 2018; Candel et al., 2014; Schubert and
Christophers, 1985). Indeed, psoriasis etiology is based on an increased
epidermal keratinocytes turnover that produces a focal coalescing
raised cutaneous plaque with consistent scaling and variable erythema
in connection to the presence of excessive infiltrating immune cells
(Büchau and Gallo, 2007). Using human biopsies and last generation
microarray technology, Pasquali et al. (2018), just recently character-
ized the keratinocyte-specific transcriptome signature of psoriasis le-
sional and non-lesional skin in psoriatic patients. Results revealed that
keratinocyte-specific gene expression in psoriatic disease is mainly en-
riched for genes related to the cell cycle, innate immunity, DNA repair/
replication, and keratinocyte development and differentiation, un-
equivocally supporting the notion that keratinocytes are significant
contributors to molecular changes in psoriasis skin.
Some causes of increased keratinocytes proliferation and disturbed
cell maturation have been suggested. Among them, the excessive pre-
sence of cAMP, the disturbed metabolism of vitamins and calcium, or
modifications in the arachidonic acid downstream signaling (Andrés
et al., 2017; Cubillos and Norgauer, 2016; Kharaeva et al., 2009;
Setkowicz et al., 2015). These theories may in part explain some of the
events occurring in psoriasis pathogenesis. However, due to critical
overlapping mechanisms and the variated immune cellular elements
occurring in the development of the disease, several aspects could be
overlooked, and much more research, particularly at the innate level is
still missing. In contrast, identification of expanded infiltrates of T-cells
in psoriatic lesions (Cai et al., 2012), composed of polarized T helper
(Th) cells populations, particularly Th1 and Th17 cells, and plenty pro-
inflammatory mediators strongly put front the adaptive T-cells as cru-
cial effectors in psoriasis (Greb et al., 2016b; Yamaguchi et al., 2018).
However, the imbalance among Th subsets shown by the Th1 and
Th17 cell increments, but not the regulatory Th2 and Treg is a matter of
interest which deserves further clarification. Whatever the case, several
excellent reviews published so far have analyzed in detail the role and
particularities of the adaptive effectors in psoriasis pathogenesis under
variated scenarios (Karczewski et al., 2016; Krueger and Bowcock,
2005; Singh et al., 2018). Nevertheless, despite the notorious advances
on the contribution of T-cells in psoriasis, up to date the complete set of
elements present in the pathogenesis of the disease is still unraveling
and far of being completely understood. Our attention here faces the
primary innate leukocytes present in the skin, namely neutrophils. On
the sequence of inflammatory events triggered at the epidermis, kera-
tinocytes initiate the response, and later the myelocytes, notably neu-
trophils take center stage in the pathogenesis of psoriasis (Ikeda et al.,
2013). This controversial notion has been extended support by the
histologic changes observed in variated animal models which resemble
psoriasis lesions, with a high detection of the archetypal pro-in-
flammatory cytokine interleukin-1 (IL-1), but with a limited presence of
T-cell infiltrates. To clarify it, Nakajima et al. (2010), following an
elegant approach using Il1rn−/- mice, clearly demonstrate the devel-
opment of cutaneous inflammation without the involvement of T-cell-
mediated immunity, confirming that T cells are not required for the
early pathogenesis of skin diseases. After that, variated information
supporting the role of innate immunity in the developmental patho-
genesis of psoriasis has emerged (Sweeney et al., 2011).
The clinical efficacy of compounds blocking the tumor necrosis
factor (TNF), a critical cytokine that induces cell survival, apoptosis,
and necrosis and contributes to both physiological and pathological
process, highly suggests a vital role of the innate immune system in
psoriasis (Boehncke and Schön, 2015; Zenz et al., 2005). TNF is con-
sidered a key messenger within the network of pro- and anti-in-
flammatory cytokines that have the capacity of triggering even its
production, as well as that of other essential cytokines in inflammatory
diseases (Kim and Moudgil, 2017). Consequently, anti-TNF therapy has
become a mainstay treatment for autoimmune diseases (Li et al., 2017).
Interestingly, despite the significant adaptive differences known be-
tween mice and human immune system, responses at the innate level
are functionally fully comparable. Using relevant murine mutant lines
to test the role of proinflammatory cytokines in the pathogenesis of skin
inflammation, was demonstrated that TNF, but not IL-6 or IL-17, is
crucial in this process (Nakajima et al., 2010). Likewise, clinical de-
velopment of early lesions in psoriasis link to periodic waves of auto-
inflammation, represented by a burst of neutrophils and their asso-
ciated cytokines related to the interleukin-1 (IL-1) family, such as IL-1α,
IL-1β, and IL-36, that along with TNF all possess a full capacity of in-
itiating the disease (Christophers et al., 2014). Mahil et al. (2017),
using knockout individuals with IL1RL2 mutations validate IL-36 as a
viable psoriasis target, proposing the development of IL-36 blockade as
a therapeutic strategy. Interestingly, the IL-36 dependent genes sig-
nature profile in keratinocytes was extensive but particularly attractive
among them is the high production of IL-17, IL-8, and CXCL1 which are
Fig. 2. Representative histologic differences between human and wild-
type zebrafish adult healthy skin. A) Human skin, when compared with B)
zebrafish skin, displays the presence of mature keratinocytes containing fibrous
proteins (keratin) and forming the stratum corneum (black asterisk) at the outer
layer. Nevertheless, both species share several characteristics at the epidermal
and basal layers. (H&E classical staining) Bars, 50 μm.
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inflammatory elements closely related to neutrophils and were all three
cytokines over expressed in psoriatic patients. Besides, Wang et al.
(2018), confirmed that increased production and activation of IL-36
might act on neutrophils and further exacerbate neutrophilic in-
flammation. To round the concept, Swindell et al. (2018), using RNA-
seq evaluated the gene expression response of primary epidermal ker-
atinocytes to stimulation by IL-1β, IL-36A, IL-36B, and IL-36G. Strik-
ingly, applying CRISPR/Cas9 mutagenesis, they demonstrate that
shared IL-1B/IL-36 responses depend entirely upon MyD88 adaptor
protein. Together, these results strongly emphasize the critical role of
innate immunity in epidermal keratinocytes and neutrophils on trig-
gering an exacerbated inflammatory response in psoriatic patients.
Here, we put forward a major question requiring an integrative
approach. Which is the role of innate immunity in the IL-23/IL-17
pathway? So far, using murine models and human psoriatic lesional
biopsies with elevated levels of IL-17 and IL-22 was demonstrate that
anti-IL17 treatment dramatically improves the psoriatic skin lesions,
regulates IL-23 and reduce inflammation by normalizing the levels of
IL-17 (Malakouti et al., 2015; Paek et al., 2018). However, the cell types
related were not identified. To do so, Reich et al. (2015), demonstrate
that a single dose of the anti-IL-17A antibody Secukinumab resulted in
skin normalization as soon as two weeks after injection, a finding
paralleled by the disappearance of IL-17+ neutrophils population, but
not the T-cells. Meanwhile, several different immune cells, out of Th17
have been recognized as IL-17 producers. Whether being still debated,
granulocytes like neutrophils and mast cells appear to synthesize IL-17
actively and release it through the formation of extracellular traps
(Brembilla et al., 2018). Strikingly, this granulocytes behavior seems to
expand well beyond psoriasis, and it extends along the vast majority of
inflammatory diseases. As an example, Lunding et al. (2016), searching
after the mechanisms underlying asthma observed that experimentally
exacerbated mice released high amounts of several proinflammatory
cytokines. Strikingly, this behavior was further associated with in-
creased IL-17 and infiltration of variated IL-17 + immune cells in an-
imals deficient either for IL-23p19 or the transcription factor RORγt,
suggesting the crucial role of neutrophils in the response. However,
caution should apply when evaluating the interrelation of these cyto-
kines and neutrophils due to several isoforms exist, and further func-
tional analyses are warranted.
3. Types of models for psoriasis research
3.1. In vitro
Several studies have evaluated psoriatic keratinocytes to identify
intrinsic defects, differentiation, proliferation, and gene expression
profile in cell culture or transplant systems (Dombrowski et al., 2011;
Piskin et al., 2006). Keratinocytes used in vitro are from diverse origins,
from intact or lesional human skin to established cell lines, like the
normal human epidermal keratinocytes (NHEK) and immortalized
human keratinocytes line (HaCaT) (Borowiec et al., 2013; Büth et al.,
2007). In vitro keratinocyte research has provided valuable information.
By themselves, however, these studies do not match in vivo psoriatic
lesions entirely, and high variability among studies is observed turning
quite tricky to draw comparisons. So far, several factors have been
proposed as the source of variation (e.g., culture temperature, serum
quality and quantity, calcium content, or lack of cell-cell interactions,
and the intraspecies variability in the biological response due to cells
commonly are isolated from individual members of the species). De-
spite clarifying the controversy, recently a transcriptomic study was
conducted applying RNA-seq technology in a primary confluent kera-
tinocytes monolayer culture grown from full-thickness punch biopsies,
and the full-thickness skin biopsies itself from psoriasis patients, and
control subjects (Swindell et al., 2017b). Results are puzzling, due to
transcriptomic findings from the in vitro study, agreed only partially
with results from full-thickness skin biopsies. These findings suggest
that analysis of full-thickness skin biopsies may obscure functionally
significant expression declines in psoriatic and normal patient kerati-
nocytes which can, in contrast, be detected from in vitro analysis of
patient-derived cells. Outcomes like this highlight the intrinsic con-
straints of the in vitro keratinocyte models of psoriasis produced at least
due to the lack of blood and cell-cell interactions in the test system and
suggest the use of direct physiological relevant models instead.
3.2. Ex-vivo
Ex-vivo models are invaluable research tools and have been used to
investigate psoriasis. In general, ex-vivo human or rat skin is excised by
abdominal surgery followed by removal of the adhering fat and visceral
tissues. Eventually, (considered as a source of variation) the skin is
rinsed thoroughly with NaCl solution before using it in the study of skin
permeation and deposition. Hydrophobic or formulated compounds
delivered by niosomes or liposomes containing gels are assayed for
percutaneous absorption studies using Franz diffusion cells (Abu
Hashim et al., 2018). Ex-vivo skin is particularly suited to address to-
pical treatments of psoriasis or sun protection with dedicated bio-
markers, such as pyrimidine dimers, p53 activation, caspase activation,
and sunburn cells, based in histology and immuno-labeling (Agarwal
et al., 2001; Bocheńska et al., 2017). However, the effect of topic
treatments assayed for permeation ex-vivo could be affected by nu-
merous combined reasons like the adsorption and fusion efficiency of
niosomes, the nanosized particles, penetration rate, the richness of lipid
in the environment, solubility and stability of compounds, or some
other factors.
3.3. Pre-clinical
Despite useful, in vitro and ex-vivo systems are by far not capable of
modeling whole-body physiology. As such, research into the patho-
genesis of psoriasis has been severely hampered by the lack of a natu-
rally occurring disorder in laboratory animals that mimic the complex
phenotype and pathogenesis of the human disease. Throughout time,
primates, dogs, pigs and several murine models related to the research
process of psoriasis have been described (Bocheńska et al., 2017;
Danilenko, 2008; Hawkes et al., 2018; Wcisło-Dziadecka et al., 2018;
Yang and Wu, 2018). The approach clearly shows the longstanding
practice of using animals for scientific purposes in biological research
and medicine. Nevertheless, now this practice turns the issue an or-
dinary matter of debate by the radical supporters of the 3R's concept
(replacement, reduction, and refinement) in our societies (Barré-
Sinoussi and Montagutelli, 2015; MacArthur Clark, 2018). Nowadays,
most current in vivo studies is conducted using one of the more than 40
unique mouse models of psoriasis described so far (Hawkes et al.,
2018). However, while many mouse models of psoriasis have been
proposed, a standardized validation criterion encompassing most
models is not widely applied. On the aim to do so, Swindell et al.
(2011), performed a whole-genome transcriptional profile study to
compare gene expression pattern manifested by human psoriatic skin
lesions with those that occur in five classical psoriasis mouse models
displaying phenotypes associated to the TLR-imiquimod, TGFβ, en-
dothelial tyrosine receptor, amphiregulin or Stat3. Results revealed that
while cutaneous gene expression profiles associated with each mouse
phenotype exhibited statistically significant similarity to the expression
profile of psoriasis in humans, each model displayed unique sets of si-
milarities and differences in comparison to human psoriasis. Several
many other studies show the double-edged pattern associated with mice
research as a model of psoriasis. A recent study demonstrates that one
of the most used mouse model of psoriasis, the TLR-imiquimod does not
produce psoriasis only, but triggers a core set of pathways active in
different skin diseases (Swindell et al., 2017a). From these reports, we
can conclude that mice are quite useful in the study of psoriasis and
have been the predominant animal bridge between the bench and the
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bedside in the past. Nevertheless, now is time to look forward and open
the door to a new complementary animal model of psoriasis, the zeb-
rafish.
4. The zebrafish as a model of skin inflammation
The use of zebrafish to investigate the genetic causes and molecular
mechanisms of psoriasis is rapidly gaining popularity. Zebrafish is a
small freshwater fish taxonomically positioned in the Cyprinid family.
Compared to rodent models, zebrafish exhibit much more efficient re-
production, rapid external development, and undefeatable optical
transparency throughout the early larval stages. Besides, zebrafish
provides infinite possibilities of experimental reproducibility due to a
daily high progeny availability (Meshalkina et al., 2017). Also, zebra-
fish enables the characterization of gene function via overexpression,
transient depletion, or genome editing by applying variated gene
editing technologies, including the latest CRISPR/Cas-based method
(Ablain et al., 2018; Varshney et al., 2015). Zebrafish are not only
embryo/larvae with robust phenotypes or genetically tractability, but
they also present accessibility optically for intravital real-time in vivo
imaging and display a fully functional innate immune system where
myeloid cells are present as soon as 24 h post fertilization (hpf) mi-
micking their mammalian counterparts (Gurevich et al., 2018; Henry
et al., 2013; Torraca and Mostowy, 2018). Besides that, the zebrafish
genome is fully sequenced, highlighting a remarkable similarity with
humans, with at least 71.4% human coding genome having a direct
ortholog in zebrafish (Howe et al., 2013; Shim et al., 2016). The Zeb-
rafish Model Organism Database (ZFIN https://zfin.org) is the central
resource where genetic, genomic, and phenotypic data on zebrafish
research is curated and run (Bradford et al., 2017). Similar to the
mouse, the zebrafish epidermis is a multilayered tissue composed by
keratinocytes, separated from the dermis by a basal membrane. In fish,
this structure is much simpler than the mammalian one, and in contrast
to terrestrial vertebrates, the skin does not function to prevent dehy-
dration due to the lack of stratum corneum (Webb et al., 2008). How-
ever, several physical similarities exist. Among them, at 24 hpf different
skin layers representing the epidermis and the dermis are separated
from the underlying tissue stroma by a basal membrane, and at 2 days
post fertilization (dpf) the lamina lucida densa can be identified (Le
Guellec et al., 2004). Interestingly, it has been observed in vitro and ex-
vivo that alteration of these elements forming paracellular barriers for
solutes and inflammatory cells, together with proinflammatory cyto-
kines are related to the early events in psoriasis (Kirschner et al., 2009).
These unique features present in the zebrafish model provides a unique
platform to further understand in vivo their functionality in the psoriatic
disease. Last but not least, in zebrafish, the lipid-rich cornified layer
observed in higher mammals is not present, and epidermis remains
metabolically active and readily available as a live substrate for ex-
perimentation throughout all life stages (Glover et al., 2013). As a
consequence, relevant zebrafish disease models of psoriasis have been
developed to aid in unraveling the complicated pathogenesis in the
human disease (Table 1).
4.1. Mutant models
Zebrafish with its extensive toolkit for genome modification and its
capacity for recapitulating human disease has found a niche among the
preclinical models of psoriasis to study and validating genetic variants,
as well as to identifying previously unrecognized disease-associated
genes. The first zebrafish model generated to study the development of
the basal epidermis and the associated mechanisms were the mutant
penner/lethal giant larva 2 (pen/lgl2). The pen/lgl2 zebrafish has a de-
fect which disrupts the basal localization of keratin cytoskeletons on
epidermal keratinocytes. This effect in humans is mediated by the lgl2
homolog, the Hugl-2 gene which is a crucial regulator of epidermal
polarity, and, in turn, keratinocyte proliferation (Zimmermann et al.,
2008). The mutant pen/lgl2 zebrafish larvae shown overgrowth of epi-
dermal cells leading to different morphological shapes and fail to form
basal hemidesmosomes, which link the epidermis to the underlying
basement membrane (Sonawane et al., 2005, 2013). Therefore, while in
pen/lgl2−/− skin detaches from the basement membrane, epidermal
cells hyperproliferate and migrate ectopically, resulting in a psoriasis-
like phenotype. Deletion also removes an essential enhancer for kera-
tinocyte differentiation, and the loss of this regulatory element allows
Table 1
Synopsis of relevant zebrafish models supporting the comparative study of human psoriatic disease.
Type Name Description Advantage Reference
(Mutant) Penner/lethal giant
larvae 2
The lack of pen/lgl2 disrupts the basal localization of
keratin cytoskeletons on fish keratinocytes.
Target the process of hemidesmosome formation,
maintenance of cytoskeletal elements, and cellular
morphology in the basal epidermis.
Sonawane et al. (2005)
Hai1a/Spint1la Keratinocytes acquire a mesenchymal-like
characteristic, lose contact, become mobile and highly
susceptible to apoptosis. Antagonistic roles between
Hai1 and St1a are produced.
Useful to uncover crucial signaling players on defects
caused by the loss of Hai1 and Matriptase 1a.
Carney et al. (2007)
Hai1 Fish embryos exhibit inflammation in areas of epidermal
hyperproliferation.
Enable the study of chronic inflammation and visualization
of immune responses with high resolution in real-time.
Mathias et al. (2007)
Psoriasis/m14 This fish exhibits widespread over proliferation of the
epidermis and a defect in keratinocyte differentiation
Allow the study of epidermal growth regulation and may
point further insights into skin development in fish.
Webb et al. (2008)
(Morphant) Tnfa-Tnfr2 Inhibition of the ligand tnfa and related receptor 2
results on neutrophil mobilization to the fish skin in
response to H2O2 derived enzyme (DUOX1) released by
keratinocytes
A robust platform to study the management of
inflammatory molecular mechanisms resulting from
oxidative stress.
Candel et al. (2014)
(Inducible) Trpv4 Explores fish new immune mechanisms mediated by a
TRPV4/TAK1/NF-κB signaling pathway that operates in
skin keratinocytes.
A convenient model to study skin inflammation resulting
from osmotic changes in the absence of commensal
microbes and functionally mature immune cells.
Galindo-Villegas et al.
(2016)
(Germ-Free) GF Fish generated following this procedure lack regular
microorganisms that may contribute to achieving a
psoriatic status.




DUOX1 Dual oxidase 1; H2O2 Hydrogen peroxide; Hai1 Hepatocyte growth factor activator inhibitor 1; NF-κB Nuclear factor kappa B; Pen/lgl2 Peener/Lethal giant
larvae; St1a Serine protease matriptase; TAK1 TGFb associated kinase 1; TNFa Tumor necrosis factor a; TNFR2 TNF receptor 2; Trpv4 Transient receptor potential
vanilloid 4.
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for the study of psoriasis association. In connection with the same, the
pen function is revealed as specifically required for the process of
hemidesmosome formation. However, suggested caution should be
applied with this model due to the disruption of lgl2 would lead to
epidermal tumor formation.
Not long after the creation of the pen/lgl2 mutant, two more lines
carrying mutations in the serine peptidase inhibitor, Kunitz type 1 a
(Spint1a), also known as Hai1a (Fig. 3A), and clathrin interactor 1a
(clint1a) genes exhibited epidermal proliferation, and keratinocytes
with mesenchymal-like characteristic (Carney et al., 2007; Dodd et al.,
2009; Mathias et al., 2007). In both models, loss of Spint1a produces
neutrophil skin infiltration and losing of contact among keratinocytes
which become mobile and highly susceptible to apoptosis (Fig. 3 B, B’
C, C’). In the Spint1a mutant, antagonistic roles between Hai1 and its
target matriptase 1a (St1a) are produced. The mutation over the Spint1a
in zebrafish enable the study of chronic inflammation and visualization
of immune responses with high resolution in real-time. These models
demonstrate their utility in the identification of functional interactions
between the keratinocytes and surrounding leukocytes (Fig. 3D, D’). At
24 hpf, the Spint1a−/− phenotype is characterized by an erratic loca-
lization of E-cadherin in epidermal cells, the fast expression of the da-
mage phenotype, and a keratinocyte hyperproliferation in regions of
cell aggregation.
An additional mutant model in this series is the Psoriasis/m14. This
zebrafish mutant model was identified resulting from a large-scale
ethylmethanesulfonate (EMS) mutagenesis screen for genes required for
zebrafish embryogenesis (Webb et al., 2008). Mutants of this fish do not
regulate cell proliferation in the epidermis late in embryogenesis and
concomitantly accumulate aggregates of epidermal cells in the embryo
surface, clearly resembling psoriasis. Besides, the late-stage epidermal
keratin is significantly reduced in this mutant fish and acts non-cell
autonomous, suggesting that it encodes an extracellular factor that
controls keratinocyte proliferation and differentiation. A loss-of-func-
tion mutation in atp1b1a, encoding the beta subunit of a Na, K-ATPase
pump, has been responsible for this phenotype (Hatzold et al., 2016).
Blockade of the ensuing PI3K-AKT-mTORC1-NF-κB-MMP9 pathway
activation in basal cells, as well as systemic isotonicity, prevents kera-
tinocyte hyperproliferation and subsequent malignant transformation.
4.2. Morphant model (knock-down)
A recent study has approached the functionality of tnfa, its receptors
(tnfr), and neutrophils behavior in the skin of zebrafish (Candel et al.,
2014). Morpholino technology producing a transient gene knock-down
cannot be used to study gene function in mice because antisense oli-
gonucleotides are rapidly diluted during mouse development (Flynt
et al., 2017). In a strict sense, morpholino is not a right genetic ap-
proach due to the possibility of producing unspecific reactions, but they
have been used extensively in zebrafish research with a high degree of
success (Kok et al., 2015). Candel et al. (2014), following elegant ap-
proaches, including morpholinos, demonstrate that the knock-down of
tnfr1 have little effect on the neutrophil trafficking in the developing
larvae at 3 dpf, while tnfa and tnfr2 had a strong effect in their mobi-
lization (Fig. 4A). Additionally, in this study the use of the transgenic
zebrafish Tg(mpx:GFP) in which neutrophils express green fluorescence
under the promoter of myeloperoxidase allow these researchers to de-
termine the particular geographical position of neutrophils. Besides,
they supported this result by applying a novel fluorescence quantifi-
cation technique and contrasted by visual inspection (Fig. 4B and C).
The specificity of the observed phenotype for the tnfr2 was confirmed
by using a dominant-negative of Tnfr2 lacking the entire intracellular
signaling domain, which phenocopy the results previously observed. To
establish other cell types, intimately related in the response whole-
mount immunohistochemistry against p63 (basal keratinocyte marker)
was conducted in morphant fish with neutrophils expressing GFP. Re-
sults revealed that mobilized neutrophils in tnfr2 deficient larvae were
in close contact with skin keratinocytes. In addition to neutrophils
mobilization, tnfr2 or tnfa morphants triggers a steady production of
master proinflammatory molecules (tnfa, il1b, and ptgs2b) through the
NF-κB pathway, resembling the phenotype of mutant spint1a and clint1a
mutant zebrafish where chronic inflammation triggers il1b production
and neutrophil infiltration. To round their results, they sorted neu-
trophils from Tg(mpx:GFP) and keratinocytes from Tg(-2.9krt18:RFP)
embryos revealing that both cell types overexpress inflammatory cy-
tokines, reflecting a positive feedback loop between both cell types
potentiating skin the inflammation. Strikingly, using an H2O2-detecting
probe, it was observed that tnfr2-deficient larvae keratinocyte activate
dual oxidase 1 (DUOX1) enzyme creating H2O2 gradients which were
sensed by neutrophils through the tyrosine kinase Lyn (Yoo et al.,
2011). Together, these results give strong support to the interplay be-
tween neutrophils and TNF-alpha which defines the immune pathology
in psoriasis.
Fig. 3. Development, and assay process of a mu-
tant zebrafish model of psoriasis disease. A)
Genomic map of hi2217 insertion and the start of the
hai1a (spint1a) open reading frame (blue) is in-
dicated (ATG); each section equals 500 bp. B, B′) In
situ hybridization of zebrafish myeloperoxidase
(mpo) at 2 dpf, arrows indicate the position of the
intermediate cell mass (ICM), the location of neu-
trophil development in zebrafish embryos (Mathias
et al., 2007). C, C′) Bright field and fluorescence
images showing lateral views of (C) wild-type sibling
(WT) and (C′) a homozygous hi2217 larvae (hai1a
−/−) mutant at 3 dpf. Ectopic keratinocyte ag-
gregates are pointed by the black arrow in the
magnified area. (D, D′) WT siblings or Mutant hi2217
were crossed with the transgenic zebrafish line Tg
(lysC:DsRed2)nz50 to visualize neutrophil (in Red)
behavior in the resulting larvae at 3 dpf. (D) In WT
fish, the white arrow indicates the basal state of
neutrophils in the CHT. (D′) While in hi2217 mutants
the presence of Hai1 affects the matriptase producing
an exacerbated behavior of neutrophils resulting in
high proliferation and massive recruitment in the
affected epidermal tissue. White dash-dot line act only as a visual guide. (For interpretation of the references to colour in this figure legend, the reader is referred to
the Web version of this article.)
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4.3. Environmental inducible models
Breaking the body balance by the environmental inputs and genetics
is often considered among the major candidates directly affecting the
onset and development of the psoriatic disease. Exploring however such
environmental insults and their associated mechanisms is a significant
challenge so far. Recent advances highlight the crucial role of the
commensal microbiota in the pathophysiology of chronic multifactorial
inflammatory disorders as well as its impact on the efficacy of ther-
apeutic agents. The skin harbors complex communities of resident mi-
croorganisms loosely organized and highly variable between different
locations among the epithelium. Recently, using state-of-the-art tech-
nologies, profound changes in DNA and RNA have been observed re-
sulting directly from the effect of microbes in psoriatic individuals
(Nibali et al., 2014). Microbiological analysis by 16S rRNA massive
sequencing of psoriatic patients shows the existence of specific tran-
scriptional signatures of microbial regulators common to both the skin
and the gastrointestinal tract (Meisel et al., 2018). Moreover, the ex-
istence of a core intestinal microbiome with a particularly marked in-
crease in Firmicutes and a decrease in Actinobacteria, compared to
healthy individuals has been well characterized (Adams et al., 2015;
Gao et al., 2008; Schommer and Gallo, 2013; Tett et al., 2017). Their
Fig. 4. Zebrafish allows the detailed in vivo study effect of key molecules and cells related to psoriasis. Transgenic zebrafish embryos microinjected with
standard control (Std), ligand/receptors of tumor necrosis factor (tnfr1, tnfr2, tnfa, or tnfr1+tnfr2) morpholinos (MO) were microscopically analyzed in real-time. (A)
Bright field and green channels, of the morphants at 3 dpf showing the differences in the neutrophils distribution. (B) Fluorescence intensity was measured for all the
groups in the area indicated (A), the CHT. (C) The neutrophil mobilization from the CHT in tnfa- and tnfr2-deficient larvae was quantified. (D) Representative dorsal
(xy) and lateral (yz) views of tridimensional reconstructions from confocal microscopy images of whole-mount immunohistochemistry of Tg(mpx:GFP) larvae stained
at 3 dpf with anti-p63 antibodies (basal keratinocyte marker, red) showing the neutrophils' distribution in the CHT area of control and tnfr2-deficient larvae (Candel
et al., 2014). Scale bars, 100 μm ns, not significant. *p < 0.05, **p < 0.01, ***p < 0.001. (For interpretation of the references to colour in this figure legend, the
reader is referred to the Web version of this article.)
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physiological roles and the molecular mechanisms mediating the host-
microbe interactions at mucosal tissues, including the skin or gut are
still under debate (Sanchez et al., 2015). With this foundational ap-
proach, to close the present knowledge gap, the use of two environ-
mental tractable zebrafish models recently generated by our group are
proposed as novel tools to elucidate critical features in the pathogenesis
of psoriasis. The germ-free (GF) zebrafish model which is based on the
principle of the commensal microbiome exclusion has been proved as
an excellent tool to perform accurately, manipulative studies with de-
fined microbial constituents triggering inflammatory mediators from
the early life stages that may lead to the development of immune-re-
lated diseases (Galindo-Villegas et al., 2012; Tobia et al., 2013). Re-
cently, we and others have found that colonization by commensal mi-
crobes in newly hatched zebrafish primes innate immunity through
TLRs and their central adaptor molecule Myd88 (Galindo-Villegas et al.,
2012; Koch et al., 2018). These findings suggest the requirement, in
addition to TLRs/Myd88 of the transcription factor NF-κB, MAPK, and
PI3K for the regulation of critical immune genes. Undoubtedly, these
data place the spotlight over the skin microbiota as an essential factor
in the inflammatory response that may play a role in the pathogenesis
of psoriasis.
Also, this disease often develops upon triggering events of me-
chanical nature leading to increased proliferation and damaged differ-
entiation of epidermal keratinocytes. In this context, some studies
highlight the impact of mechanical forces and mechano-transduction
during triggering events of the disease, therefore inducing mechano-
regulated signaling pathways in keratinocytes. Emerging pieces of
evidence suggest that many polymodal transient receptor potential
(TRP) channels are critically related to it, and consequently in the de-
velopment and further regulation of psoriasis (Caterina and Pang, 2016;
Malakou et al., 2018). Mainly, TRP vanilloid 4 (TRPV4) is an epidermal
channel linked directly to barrier functions and cell proliferation
(Olivan-Viguera et al., 2018). Recently, using zebrafish embryos, we
have uncovered a previously unappreciated role of the skin in the ac-
tivation of developmental immunity in keratinocytes mediated by the
TRPV4 channel (Galindo-Villegas et al., 2016). In 24 hpf zebrafish
embryos, positive immune cells are not present in high numbers to
mediate an inflammatory response. Thus, keratinocytes “take the
function of neutrophils” following the environmental insult and pro-
duce and release variated powerful inflammatory mediators (Fig. 5A).
Of particular relevance in our model is that osmotic stress regulates the
activation of immunity and host protection in newly hatched embryos.
Mechanistically, skin keratinocytes were responsible for both sensing
the hyposmolarity of the aquatic environment and mediating immune
effector mechanisms. This effect occurred through a TRPV4/Ca2+/
TGFβ-activated kinase 1(TAK1)/NF-κB signaling pathway. Notably, in
support of this appreciation, the combinatorial zebrafish model does
not trigger an inflammatory process if embryos remain under the pro-
tection of their chorions. Thus, our findings suggest that drugs targeting
the TRPV4 channel (Fig. 5B) or the associated signaling pathway to-
gether with the selective manipulation of commensal microbes may be
useful in treating chronic inflammatory skin disorders, such as psoriasis
(Galindo-Villegas et al., 2016; Montalban-Arques et al., 2015). Never-
theless, despite zebrafish embryos are highly promising as a powerful
tool for high-throughput drug screening of TRPV4 antagonists, or some
related pharmacological drugs, further studies should explore in much
detail how hyposmolarity regulate the crosstalk between the skin,
commensals attach and the immune cells.
5. Summary/future directions
Here, we have provided a short overview of many current vertebrate
disease models developed so far as to understand psoriasis disease.
Impressive findings have been achieved, many of them already applied
in patients or under investigation in biomedical phase III. Nevertheless,
substantial gaps remain to be sorted before providing definitive and
Fig. 5. Keratinocytes sense the presence of bacteria and osmotic changes to activate the immune system. Environmental insults trigger inflammation in the
skin A) Tail views of tridimensional reconstructions from confocal microscopy images of whole-mount immunohistochemistry of 52 hpf germ-free (GF) or con-
ventionally (CONR) raised zebrafish larvae subjected or not to hypoosmotic shock for 4 h, and then stained with anti-P63 (basal keratinocyte marker, green) or anti-
Il1b (inflammatory marker, magenta) antibodies. B) Keratinocytes sense hyposmotic changes trough TRPV4. Confocal microscopy images of the tail from whole-
mount 72 hpf CONR Tg(-2.9krt18:RPF) zebrafish, immunostained specimens for Trpv4 (green) and RPF (magenta). Merged image shows the Trpv4 signal colocalized
over Krt18 positive keratinocytes (red arrows) (Galindo-Villegas et al., 2016). Scale bars, 100 μm. (For interpretation of the references to colour in this figure legend,
the reader is referred to the Web version of this article.)
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universal conclusions on the pathogenesis of this disease. Notably, we
illustrated significant advances obtained by using classical psoriasis
models which partially recapitulate the human disease. However, fur-
ther, we highlight the impressive features intrinsic to zebrafish, a novel
organism that may provide fundamental advances on the molecular
mechanisms associated with keratinocytes and neutrophils at the early
stages of the psoriatic disease. The power of the model is solely based
on the zebrafish simple skin structure, and the high similarity to the
human epithelium and the potent immune mediators it produces in
compromised conditions (Fig. 6A and B) On this perspective a myriad of
environmental, genetic and drug screening tests can be conducted, and
aid on enabling rapid discovery of possible chemical targets. Finally, in
further research applying this model the identification and under-
standing of crucial aspects of epigenetic, post-translational modifica-
tions, host-microbe interactions, and trained immunity (all possible
using zebrafish) could help on bridging the gap between genetic and
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